Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diractin (IDEA-033) vs Celecoxib in Knee Osteoarthritis
NCT00317733Phase 2Completed
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of ketoprofen in knee osteoarthritis (OA) (3 arms). Primary endpoints: Visual Analog Scale (VAS) of the Western Ontario and McMaster Universities Index (WOMAC) pain subscale at 6 weeks, Visual Analog Scale (VAS) of the Western Ontario and McMaster Universities Index (WOMAC) function subscale at 6 weeks and 1 more. Status: completed.
02
Drugs
ketoprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00317733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317733.